查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713580

2025年全球流动止血钳市场报告

Flowable Hemostats Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年流动止血钳市场规模将强劲成长。到 2029 年，这一数字将成长至 13.7 亿美元，年复合成长率（CAGR）为 7.6%。预测期内的增长是由于外科手术数量的增加、慢性病盛行率的上升、对微创手术的需求不断增长以及需要外科治疗的老年人口的增加。预测期内的关键趋势包括先进生物工程材料的整合、智慧止血材料的开发、机器人辅助和微创手术技术、采用针对患者和个人化的止血解决方案以及止血材料的高级客製化。

流动止血钳市场的成长是由外科手术数量的增加所推动的。这种增长是由于人口老化增加了与老龄化相关的手术的需求，以及技术进步使得手术更安全、更容易获得。流动止血钳在外科手术中特别有用，可以控制难以触及的区域或传统方法无效的出血。例如，美国专业非政府组织国际美容整形外科学会（ISAPS）2024年6月的报告显示，2023年全球手术和非手术整形总数与前一年同期比较去年同期成长3.4%，达到3,490万例。因此，手术数量的增加促进了流动止血材料市场的扩大。

流动止血剂市场的主要企业正致力于开发无膨胀技术等先进止血剂，以满足外科手术不断变化的需求。 No-Swell 技术是一种在吸收液体时不会膨胀的止血剂，使其成为肿胀可能导致併发症的手术的理想选择。例如，2023年1月，美国外科技术公司Medcura Inc.凭藉其LifeGel流体技术获得FDA突破性医疗设备称号。 LifeGel 旨在控製手术期间无法忍受肿胀的出血。它是第一种也是唯一一种专门解决止血肿胀相关问题的流动止血凝胶。这种可吸收药物可保持水分而不会肿胀，可随时使用，可能降低神经损伤和瘫痪的风险。它具有成本效益、抗菌、相对透明且黏附于组织的特点，为复杂手术过程中的出血控制提供了更安全、更有效的解决方案。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球流动性静态材料PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球流动止血钳市场：成长率分析
  • 全球流动止血钳市场表现：规模与成长，2019-2024 年
  • 全球流动止血钳市场预测：规模与成长，2024-2029 年，2034 年预测
  • 全球液体止血剂总目标市场（TAM）

第六章市场区隔

  • 全球流动止血钳市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 主动止血剂
  • 被动止血剂
  • 复合止血钳
  • 全球流动止血钳市场：按材料、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 猪肉明胶
  • 牛明胶
  • 全球流动止血钳市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 一般外科
  • 心血管手术
  • 血管外科
  • 神经脊椎手术
  • 整形外科
  • 其他用途
  • 全球流动止血钳市场：依最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 门诊手术中心
  • 全球流动止血钳市场，依主动止血钳类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 纤维蛋白胶
  • 凝血酶类止血剂
  • 胶原蛋白基止血剂
  • 生物分解性生物降解高分子止血材料
  • 全球流动止血剂市场细分（依被动止血剂类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 纱布止血钳
  • 海绵和垫片
  • 纤维素止血材料
  • 颗粒止血剂
  • 全球流动止血剂市场复合止血剂细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 纤维蛋白原和凝血酶组合产品
  • 胶原蛋白和纤维蛋白组合产品
  • 合成复方止血剂
  • 生物可吸收复合止血材料

第七章 区域和国家分析

  • 全球流动止血钳市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球流动止血钳市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 液体止血剂市场：竞争格局
  • 流动止血钳市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Baxter International Inc.
  • B Braun Melsungen AG
  • Becton Dickinson and Company
  • Cook Medical Inc.
  • Teleflex Incorporated
  • Mallinckrodt Pharmaceuticals
  • Integra LifeSciences Holdings Corporation
  • Gelita Medical GmbH
  • Ferrosan Medical Devices A/S
  • Marine Polymer Technologies Inc
  • Axio Biosolutions Private Limited
  • Hemostasis LLC
  • Aegis Lifesciences Private Limited
  • Medcura Health Inc
  • Arch Therapeutics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年流动止血钳市场：提供新机会的国家
  • 2029 年流动止血钳市场：细分市场带来新机会
  • 2029 年流动止血钳市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33482

Flowable hemostats are gelatinous medical devices designed to control bleeding during surgery by adapting to irregular wound shapes for effective application. They aid clotting by creating a physical barrier and activating the body's coagulation cascade, making them suitable for use in complex or delicate surgical areas.

The main types of flowable hemostats are active hemostats, passive hemostats, and combination hemostats. Active hemostats are specialized medical agents that actively contribute to the blood clotting process, enhancing hemostasis during surgeries or in bleeding situations. They can be made from materials such as porcine gelatin and bovine gelatin and are used in various surgical fields, including general, cardiac, vascular, neuro and spine, and orthopedic surgeries. These hemostats are designed to meet the needs of different end users, including hospitals, clinics, and ambulatory surgery centers.

The flowable hemostats market research report is one of a series of new reports from The Business Research Company that provides flowable hemostats market statistics, including flowable hemostats industry global market size, regional shares, competitors with a flowable hemostats market share, detailed flowable hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the flowable hemostats industry. This flowable hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The flowable hemostats market size has grown strongly in recent years. It will grow from $0.95 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to growth in elective surgeries, rising adoption of personalized medicine, increased healthcare spending, and expansion of healthcare infrastructure in emerging markets.

The flowable hemostats market size is expected to see strong growth in the next few years. It will grow to $1.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the increasing number of surgical procedures, rising prevalence of chronic diseases, growing demand for minimally invasive surgeries, and an expanding geriatric population requiring surgical care. Major trends in the forecast period include integration of advanced bioengineered materials, development of smart hemostatic products, robotic-assisted and minimally invasive surgical techniques, adoption of patient-specific and personalized hemostatic solutions, and advanced customization of hemostats.

The growth of the flowable hemostats market is expected to be driven by the rising number of surgical procedures. This increase is attributed to an aging population, which creates a higher demand for age-related surgeries, as well as technological advancements that have made surgeries safer and more accessible. Flowable hemostats are particularly valuable in surgical procedures for controlling bleeding in hard-to-reach areas or where traditional methods might be ineffective. For example, in June 2024, a report by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, revealed that the total number of surgical and non-surgical procedures increased by 3.4% in 2023, reaching 34.9 million compared to the previous year. Thus, the growing number of surgical procedures is contributing to the expansion of the flowable hemostats market.

Major companies in the flowable hemostats market are concentrating on developing advanced hemostatic agents, such as no-swell technology, to meet the evolving needs of surgical procedures. No-swell technology describes a hemostatic agent that does not absorb fluids and expand, making it suitable for surgeries where swelling could lead to complications. For example, in January 2023, Medcura Inc., a US-based surgical technology company, received FDA breakthrough device designation for its LifeGel flowable technology. LifeGel is designed to control bleeding during surgeries where swelling is not acceptable. It is the first and only flowable hemostatic gel specifically addressing issues related to hemostatic swelling. The absorbable agent remains hydrated and ready-to-use without swelling, potentially reducing risks such as nerve injury and paralysis. It is cost-effective, retains antimicrobial properties, is relatively transparent, and adheres to tissues, offering a safer and more effective solution for managing bleeding in complex surgical procedures.

In May 2022, Ethicon, a company based in the United States that specializes in surgical technologies, purchased GATT Technologies B.V. for an undisclosed sum. The goal of this acquisition was to strengthen Ethicon's portfolio of hemostatic and sealant solutions by incorporating GATT Technologies' advanced products to enhance surgical results. GATT Technologies B.V., located in the Netherlands, is recognized for its innovative advancements in hemostatic and sealant products used in medical applications.

Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

North America was the largest region in the flowable hemostats market in 2024. The regions covered in the flowable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the flowable hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The flowable hemostats market consists of sales of synthetic flowable hemostats, fibrin sealant-based hemostats, and collagen-based flowable hemostats. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Flowable Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on flowable hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for flowable hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The flowable hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats
  • 2) By Material: Porcine Gelatin; Bovine Gelatin
  • 3) By Application: General Surgery; Cardiac Surgery; Vascular Surgery; Neuro And Spine Surgery; Orthopedic Surgery; Other Applications
  • 4) By End User: Hospital And Clinics; Ambulatory Surgery Centers
  • Subsegments:
  • 1) By Active Hemostats: Fibrin Sealants; Thrombin-Based Hemostats; Collagen-Based Hemostats; Biodegradable Polymer Hemostats
  • 2) By Passive Hemostats: Gauze-Based Hemostats; Sponges and Pads; Cellulose-Based Hemostats; Granule-Based Hemostats
  • 3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products; Collagen and Fibrin Combination Products; Synthetic Combination Hemostats; Bioresorbable Combination Hemostats
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Medtronic plc; Medline Industries Inc.; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Flowable Hemostats Market Characteristics

3. Flowable Hemostats Market Trends And Strategies

4. Flowable Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Flowable Hemostats Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Flowable Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Flowable Hemostats Market Growth Rate Analysis
  • 5.4. Global Flowable Hemostats Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Flowable Hemostats Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Flowable Hemostats Total Addressable Market (TAM)

6. Flowable Hemostats Market Segmentation

  • 6.1. Global Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Active Hemostats
  • Passive Hemostats
  • Combination Hemostats
  • 6.2. Global Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Porcine Gelatin
  • Bovine Gelatin
  • 6.3. Global Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • General Surgery
  • Cardiac Surgery
  • Vascular Surgery
  • Neuro And Spine Surgery
  • Orthopedic Surgery
  • Other Applications
  • 6.4. Global Flowable Hemostats Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital And Clinics
  • Ambulatory Surgery Centers
  • 6.5. Global Flowable Hemostats Market, Sub-Segmentation Of Active Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fibrin Sealants
  • Thrombin-Based Hemostats
  • Collagen-Based Hemostats
  • Biodegradable Polymer Hemostats
  • 6.6. Global Flowable Hemostats Market, Sub-Segmentation Of Passive Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gauze-Based Hemostats
  • Sponges and Pads
  • Cellulose-Based Hemostats
  • Granule-Based Hemostats
  • 6.7. Global Flowable Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fibrinogen and Thrombin Combination Products
  • Collagen and Fibrin Combination Products
  • Synthetic Combination Hemostats
  • Bioresorbable Combination Hemostats

7. Flowable Hemostats Market Regional And Country Analysis

  • 7.1. Global Flowable Hemostats Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Flowable Hemostats Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Flowable Hemostats Market

  • 8.1. Asia-Pacific Flowable Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Flowable Hemostats Market

  • 9.1. China Flowable Hemostats Market Overview
  • 9.2. China Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Flowable Hemostats Market

  • 10.1. India Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Flowable Hemostats Market

  • 11.1. Japan Flowable Hemostats Market Overview
  • 11.2. Japan Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Flowable Hemostats Market

  • 12.1. Australia Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Flowable Hemostats Market

  • 13.1. Indonesia Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Flowable Hemostats Market

  • 14.1. South Korea Flowable Hemostats Market Overview
  • 14.2. South Korea Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Flowable Hemostats Market

  • 15.1. Western Europe Flowable Hemostats Market Overview
  • 15.2. Western Europe Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Flowable Hemostats Market

  • 16.1. UK Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Flowable Hemostats Market

  • 17.1. Germany Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Flowable Hemostats Market

  • 18.1. France Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Flowable Hemostats Market

  • 19.1. Italy Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Flowable Hemostats Market

  • 20.1. Spain Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Flowable Hemostats Market

  • 21.1. Eastern Europe Flowable Hemostats Market Overview
  • 21.2. Eastern Europe Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Flowable Hemostats Market

  • 22.1. Russia Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Flowable Hemostats Market

  • 23.1. North America Flowable Hemostats Market Overview
  • 23.2. North America Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Flowable Hemostats Market

  • 24.1. USA Flowable Hemostats Market Overview
  • 24.2. USA Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Flowable Hemostats Market

  • 25.1. Canada Flowable Hemostats Market Overview
  • 25.2. Canada Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Flowable Hemostats Market

  • 26.1. South America Flowable Hemostats Market Overview
  • 26.2. South America Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Flowable Hemostats Market

  • 27.1. Brazil Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Flowable Hemostats Market

  • 28.1. Middle East Flowable Hemostats Market Overview
  • 28.2. Middle East Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Flowable Hemostats Market

  • 29.1. Africa Flowable Hemostats Market Overview
  • 29.2. Africa Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Flowable Hemostats Market Competitive Landscape And Company Profiles

  • 30.1. Flowable Hemostats Market Competitive Landscape
  • 30.2. Flowable Hemostats Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Flowable Hemostats Market Other Major And Innovative Companies

  • 31.1. Baxter International Inc.
  • 31.2. B Braun Melsungen AG
  • 31.3. Becton Dickinson and Company
  • 31.4. Cook Medical Inc.
  • 31.5. Teleflex Incorporated
  • 31.6. Mallinckrodt Pharmaceuticals
  • 31.7. Integra LifeSciences Holdings Corporation
  • 31.8. Gelita Medical GmbH
  • 31.9. Ferrosan Medical Devices A/S
  • 31.10. Marine Polymer Technologies Inc
  • 31.11. Axio Biosolutions Private Limited
  • 31.12. Hemostasis LLC
  • 31.13. Aegis Lifesciences Private Limited
  • 31.14. Medcura Health Inc
  • 31.15. Arch Therapeutics Inc.

32. Global Flowable Hemostats Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Flowable Hemostats Market

34. Recent Developments In The Flowable Hemostats Market

35. Flowable Hemostats Market High Potential Countries, Segments and Strategies

  • 35.1 Flowable Hemostats Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Flowable Hemostats Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Flowable Hemostats Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33482_Flowable_Hemostats_GMR_2025